Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05419245Unknown

Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome

Role: lead

NCT05419609Not ApplicableUnknown

Comparison of an Office-based Limited Facelift and Hospital-based Full Facelift

Role: lead

NCT03872544Unknown

Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Role: lead

NCT03880188Unknown

Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Role: lead

All 4 trials loaded